LIVN
LivaNova PLCPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 25 ▲ LivaNova reported strong full-year 2025 results with double-digit re…
- May 6 ▲ LivaNova reported Q1 2026 revenue of $362.3M (+14.3% YoY reported, +…
- May 26 ▼ 1 insider sell $136.3K at $75.75
- Jun 15 ▼ 1 insider sell $96.2K at $80.19
- Jul 1 Freedom Capital Markets initiates
- Aug 5 ▲ LivaNova reported Q2 2026 revenue of $390.6M (+10.8% YoY) and adjust…
- Aug 11 ▼ 1 insider sell $207.9K at $77.74
- Aug 31 to Sep 10 ▼ 3 days of insider sells: $591.8K by 2 insiders, avg $79.44
- Oct 7 Barclays initiates
- Nov 4 ▲ Earnings: LIVN Q3 2026 Earnings: EPS $1.23 (+14.1% vs est)
- Nov 4 ▲ LivaNova reported Q3 2026 revenue of $393.1M (+9.9% YoY reported, +1…
- Nov 12 ▼ 1 insider sell $227.3K at $90.91
Signal stack
Where each data set points today.
- InsidersBEARISH
4 insiders sold $1.3M.
- InstitutionsBULLISH
Q3 2026: 21 added (0 new), 12 trimmed or exited.
- AnalystsBULLISH
13 of 16 rate it Buy or better. Median target $110.00 (+19%).
- Short sellersSTEADY
Short interest +2.6% to 6.36M shares. 12.4 days to cover, ≈11.6% of shares.
- TrendUPTREND
15% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | ADD | $304.2M |
| Invesco Ltd. | ADD | $222.9M |
| UBS Group AG | ADD | $41.1M |
| BARCLAYS PLC | ADD | $22.1M |
| PRINCIPAL FINANCIAL GROUP INC | ADD | $19.3M |
| HRT FINANCIAL LP | DOUBLED | $14.6M |
| Squarepoint Ops LLC | DOUBLED | $10.0M |
| Verition Fund Management LLC | DOUBLED | $9.7M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
16 analystsPrice is inside the target range. Median implies +19%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 9, 2026 | Barclays MAINTAIN | Overweight |
| Nov 5, 2026 | Baird MAINTAIN | Outperform |
| Nov 4, 2026 | Needham MAINTAIN | Buy |
| Oct 7, 2026 | Barclays INITIATE | Overweight |
| Sep 2, 2026 | Piper Sandler REITERATE | Overweight |
| Aug 5, 2026 | Needham MAINTAIN | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Shvartsburg Alex Chief Financial Officer Nov 12, 2026 | SELL | $227.3K |
Liddy Anne M. Chief Legal Officer Sep 15, 2026 | AWARD | 6,291 sh |
Bianchi Francesco Director Sep 10, 2026 | SELL | $273.0K |
Story Brooke Director Sep 4, 2026 | SELL | $187.3K |
Bianchi Francesco Director Aug 31, 2026 | SELL | $131.5K |
Tezel Ahmet Chief Innovation Officer Aug 11, 2026 | TO ISSUER | $668.7K |
Tezel Ahmet Chief Innovation Officer Aug 11, 2026 | EXERCISE | $668.6K |
Tezel Ahmet Chief Innovation Officer Aug 11, 2026 | TAX W/H | $111.2K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | $1.06 | $0.99–$1.13 | -0.9% | $386.5M |
| Current FY | $4.43 | $4.40–$4.46 | +1.8% | $1.5B |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
10 filings · 4 bullish · 0 bearish · 6 neutral- NEUTRAL 144Nov 12, 2026
Alex Shvartsburg, an officer of LivaNova PLC, filed a Form 144 notice of intent to sell 2,500…
The proposed sale is small in size and appears to be a routine diversification move by an officer. Monitor for any subsequent Form 4 filings to confirm execution; no material impact expected.
- NEUTRAL SC 13GNov 10, 2026
Invesco Ltd. filed a Schedule 13G disclosing a 5.3% passive stake in LivaNova PLC as of September…
Invesco's new 5.3% passive stake adds to the institutional ownership base alongside Fidelity's 7.1% and Millennium's position. Monitor for any future 13D conversion or stake increases, though the…
- NEUTRAL SC 13G/ANov 5, 2026
FMR LLC (Fidelity) filed an amended Schedule 13G reporting a 7.1% passive stake in LivaNova as of…
The incremental stake increase is routine for a large passive manager and does not signal a change in investment thesis. Monitor future 13F filings for any shift in Fidelity's position sizing…
- BULLISH 8-KNov 4, 2026
LivaNova reported Q3 2026 revenue of $393.1M (+9.9% YoY reported, +10.0% constant-currency), above…
The raised guidance and strong double-digit growth in both segments signal sustained momentum. Watch for Q4 execution on the new oxygenator line and the 2028 CPT code catalyst for sleep apnea therapy.
All LIVN filing & press-release reports (10)
- 144 reportNov 12, 2026
- SC 13G reportNov 10, 2026
- SC 13G/A reportNov 5, 2026
- 8-K reportNov 4, 2026
- CLUSTER reportSep 14, 2026
- CLUSTER reportSep 8, 2026
- 8-K reportAug 5, 2026
- 8-K reportMay 6, 2026
- DEFA14A reportApr 29, 2026
- 8-K reportFeb 25, 2026